Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

(2013) Mathias J Rummel et al.   LANCET

An upward trend in the age-specific incidence patterns for mantle cell lymphoma in the USA

(2013) Briseis Aschebrook-Kilfoy et al.   LEUKEMIA & LYMPHOMA

Radioimmunotherapy in mantle cell lymphoma

(2012) Alan P. Skarbnik et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma

(2012) L. Nygren et al.   BLOOD

The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL

(2012) C. Muller et al.   BLOOD

Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur

(2012) Christian H. Geisler et al.   BRITISH JOURNAL OF HAEMATOLOGY

Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret Hospital

(2012) Maryse Bernard et al.   LEUKEMIA & LYMPHOMA

Treatment of Older Patients with Mantle-Cell Lymphoma

(2012) H.C. Kluin-Nelemans et al.   NEW ENGLAND JOURNAL OF MEDICINE

Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma

(2011) R. Griffiths et al.   BLOOD

Mantle cell lymphoma

(2011) Sergio Cortelazzo et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Marked improvement of overall survival in mantle cell lymphoma: a population based study from the Swedish Lymphoma Registry

(2011) Anna Abrahamsson et al.   LEUKEMIA & LYMPHOMA

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

(2010) V. Fernandez et al.   CANCER RESEARCH

Validation, revision and extension of the Mantle Cell Lymphoma International Prognostic Index in a population-based setting

(2010) S. A. M. van de Schans et al.   HAEMATOLOGICA

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

(2008) C. H. Geisler et al.   BLOOD

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

(2008) Annina Herrmann et al.   JOURNAL OF CLINICAL ONCOLOGY

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

(2007) E. Hoster et al.   BLOOD